Mesalazine use tactics in the ulcerative colitis patients
Aim of the lecture. To specify indications for the administration of the 5-aminosalicylic acid (5-АSA) in the patients with ulcerative colitis (UC) and to discuss the possibility of correlation between the body mass index, the disease activity and reasonability for the prescription of the mesalazine...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2013-03-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1185 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1823860088552554496 |
---|---|
author | A. V. Korolev O. Z. Okhlobystina L. N. Androsova O. S. Shifrin |
author_facet | A. V. Korolev O. Z. Okhlobystina L. N. Androsova O. S. Shifrin |
author_sort | A. V. Korolev |
collection | DOAJ |
description | Aim of the lecture. To specify indications for the administration of the 5-aminosalicylic acid (5-АSA) in the patients with ulcerative colitis (UC) and to discuss the possibility of correlation between the body mass index, the disease activity and reasonability for the prescription of the mesalazine (Pentasa) as a monotherapy.Key points. 5-АSA is the first line drug for the UC patients. The efficacy has been demonstrated in a huge number of studies, the indications for the administration have been determined and are dependent on the disease activity index. 5-АSA are used in moderate rate of the inflammatory activity. This article discusses the question of the possible relation between the body mass loss during the disease, www.m-vesti.ru and the body mass index as the additional factors for the determining of the pathological process activity and the indications for the prescription of the 5-АSA drugs. The article points out the possibility of the mesalazine rectal suppositories use for proctitis in the patients with UC that increases the adhesion of the patients to the treatment.Conclusion. Mesazaline is efficient in the UC patients with both distal as well as extended forms of the disease. The additional factor which determines the disease activity is probably the patients’ nutritional status which is expedient to be taken into account while selecting the therapy. |
format | Article |
id | doaj-art-e4871afabc844c5ba7372dad4ebc1efa |
institution | Kabale University |
issn | 1382-4376 2658-6673 |
language | Russian |
publishDate | 2013-03-01 |
publisher | Gastro LLC |
record_format | Article |
series | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
spelling | doaj-art-e4871afabc844c5ba7372dad4ebc1efa2025-02-10T16:14:39ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732013-03-012315256769Mesalazine use tactics in the ulcerative colitis patientsA. V. Korolev0O. Z. Okhlobystina1L. N. Androsova2O. S. Shifrin3I.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityAim of the lecture. To specify indications for the administration of the 5-aminosalicylic acid (5-АSA) in the patients with ulcerative colitis (UC) and to discuss the possibility of correlation between the body mass index, the disease activity and reasonability for the prescription of the mesalazine (Pentasa) as a monotherapy.Key points. 5-АSA is the first line drug for the UC patients. The efficacy has been demonstrated in a huge number of studies, the indications for the administration have been determined and are dependent on the disease activity index. 5-АSA are used in moderate rate of the inflammatory activity. This article discusses the question of the possible relation between the body mass loss during the disease, www.m-vesti.ru and the body mass index as the additional factors for the determining of the pathological process activity and the indications for the prescription of the 5-АSA drugs. The article points out the possibility of the mesalazine rectal suppositories use for proctitis in the patients with UC that increases the adhesion of the patients to the treatment.Conclusion. Mesazaline is efficient in the UC patients with both distal as well as extended forms of the disease. The additional factor which determines the disease activity is probably the patients’ nutritional status which is expedient to be taken into account while selecting the therapy.https://www.gastro-j.ru/jour/article/view/1185ulcerative colitis5-aminosalicylic acidnutritional status |
spellingShingle | A. V. Korolev O. Z. Okhlobystina L. N. Androsova O. S. Shifrin Mesalazine use tactics in the ulcerative colitis patients Российский журнал гастроэнтерологии, гепатологии, колопроктологии ulcerative colitis 5-aminosalicylic acid nutritional status |
title | Mesalazine use tactics in the ulcerative colitis patients |
title_full | Mesalazine use tactics in the ulcerative colitis patients |
title_fullStr | Mesalazine use tactics in the ulcerative colitis patients |
title_full_unstemmed | Mesalazine use tactics in the ulcerative colitis patients |
title_short | Mesalazine use tactics in the ulcerative colitis patients |
title_sort | mesalazine use tactics in the ulcerative colitis patients |
topic | ulcerative colitis 5-aminosalicylic acid nutritional status |
url | https://www.gastro-j.ru/jour/article/view/1185 |
work_keys_str_mv | AT avkorolev mesalazineusetacticsintheulcerativecolitispatients AT ozokhlobystina mesalazineusetacticsintheulcerativecolitispatients AT lnandrosova mesalazineusetacticsintheulcerativecolitispatients AT osshifrin mesalazineusetacticsintheulcerativecolitispatients |